Follow
International Journal of Current Microbiology and Applied Sciences (IJCMAS)
IJCMAS is now DOI (CrossRef) registered Research Journal. The DOIs are assigned to all published IJCMAS Articles.
Index Copernicus ICI Journals Master List 2022 - IJCMAS--ICV 2022: 95.28 For more details click here
National Academy of Agricultural Sciences (NAAS) : NAAS Score: *5.38 (2020) [Effective from January 1, 2020] For more details click here

Login as a Reviewer


See Guidelines to Authors
Current Issues
Download Publication Certificate

Original Research Articles                      Volume : 10, Issue:8, August, 2021

PRINT ISSN : 2319-7692
Online ISSN : 2319-7706
Issues : 12 per year
Publisher : Excellent Publishers
Email : editorijcmas@gmail.com /
submit@ijcmas.com
Editor-in-chief: Dr.M.Prakash
Index Copernicus ICV 2018: 95.39
NAAS RATING 2020: 5.38

Int.J.Curr.Microbiol.App.Sci.2021.10(8): 620-628
DOI: https://doi.org/10.20546/ijcmas.2021.1008.072


Pernicious Combination of Covid-19 and Mucormycosis
Vijayalakshmi Nayak1 and R. Shyamala2*
1Department of Dermatology,
2Department of Microbiology, AIIMS Bibinagar, Hyderabad, Telangana, India
*Corresponding author
Abstract:

During the pandemic, the combination of covid 19 with systemic steroids has caused a dramatic increase in the Mucormycosis cases in India. Our narrative review aims to understand the possible pathomechanisms involved in this exponential increase of Mucormycosis cases. The pathogen's virulence depends on the organism's ability to survive in the host by evading the immune system and causing harm to the host cells. Factors involved in the pathogenesis of COVID 19 which might be interested in the pathomechanisms of Mucormycosis are (1) increased expression of GRP 78 receptors (2) alteration of iron metabolism – the role of ferritin and iron (3) hepcidin mimicking activity (4) endothelities (5) damage to beta islet cells of pancreas (6) use of corticosteroid. Heath care-related or nosocomial infection though rare, can not be neglected. Mucormycosis developed in patients with both active SAR-CoV infection and patients who had recovered from COVID19 illness. Mucormycosis involving the nose and sinuses was the most common type. Early diagnosis and treatment of Mucormycosis are essential, as it improves the outcome and decreases the need for surgical intervention hence disfigurement. The combination of COVID 19 infection, steroid use, diabetes, and hospitalisation has caused a surge in Mucormycosis cases in COVID 19 infected patients. Further understanding of the pathogenesis helps in taking measures in the prevention and early management of the infection.


Keywords: Aspergillosis, acute respiratory distress syndrome, pneumonia

Download this article as Download

How to cite this article:

Vijayalakshmi Nayak and Shyamala, R. 2021. Pernicious Combination of Covid-19 and Mucormycosis.Int.J.Curr.Microbiol.App.Sci. 10(8): 620-628. doi: https://doi.org/10.20546/ijcmas.2021.1008.072
Copyright: This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike license.

Citations